BackPAVmed- Warrants (29/01/2022) Overview

PAVmed- Warrants (29/01/2022) Accounts Payable

Track PAVmed- Warrants (29/01/2022)'s accounts payable ($1.1M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$1.06M
99.73% YoYΔ $-385.94M vs prior year quarter

Peer trimmed avg / median

Loading

PAVmed- Warrants (29/01/2022) Accounts Payable History

Loading

PAVmed- Warrants (29/01/2022) vs. peers: Accounts Payable Comparison

Loading

PAVmed- Warrants (29/01/2022) Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

PAVmed- Warrants (29/01/2022) (PAVMW) FAQ

As of the most recent data (June 2026), PAVMW shows a accounts payable of $1.1M. That compares with $390M in the prior-year period — down 99.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PAVMW's accounts payable is now $1.1M (was $390M) — a 99.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether PAVmed- Warrants (29/01/2022) is outperforming or lagging.

Tracking PAVMW's accounts payable over time shows whether PAVmed- Warrants (29/01/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.1M That compares with $390M in the prior-year period — down 99.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has PAVmed- Warrants (29/01/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $1.1M) with ownership activity and broader fundamentals.

PAVmed- Warrants (29/01/2022)'s accounts payable is $1.1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.